Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio. uri icon

authors

  • Pak, Kyongsun
  • Uno, Hajime
  • Dae Hyun Kim, MD, MPH, ScD
  • Tian, Lu
  • Kane, Robert C
  • Takeuchi, Masahiro
  • Fu, Haoda
  • Claggett, Brian
  • Wei, Lee-Jen

publication date

  • January 1, 2017